Drug profile · INN
ceftobiprole medocaril sodium
ZEVTERA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
ceftobiprole medocaril sodium (ZEVTERA) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN ceftobiprole medocaril sodium
Brand ZEVTERA
Route INTRAVENOUS
Formulation POWDER
Frequently asked questions
What is ceftobiprole medocaril sodium?
ceftobiprole medocaril sodium (ZEVTERA) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for ceftobiprole medocaril sodium?
ZEVTERA is a marketed brand name for ceftobiprole medocaril sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ceftobiprole medocaril sodium?
ceftobiprole medocaril sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.